Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer
Clinical trial NCT02769832 · COMPLETED
Trial details
- NCT number
- NCT02769832
- Sponsor
- Muhammad Furqan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-29
- Primary completion
- 2021-09-23
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.